| Aktie | Ticker | 2025/Q4 | 2025/Q3 | ||
|---|---|---|---|---|---|
| Investment ($) | QoQ Veränd. ($) | Investment ($) | QoQ Veränd. ($) | ||
| 1.565.452.855 $ | +249.513.234 $ | 1.343.110.955 $ | +1.343.110.955 $ | ||
| BANK OF AMERICA CORP /DE/ | BAC | 1.263.182.561 $ | +199.602.853 $ | 1.063.579.708 $ | +1.063.579.708 $ |
| Syndax Pharmaceuticals Inc | SNDX | 169.150.649 $ | +38.070.449 $ | 131.080.200 $ | +131.080.200 $ |
| BIOCRYST PHARMACEUTICALS INC | BCRX | 73.058.903 $ | +1.786.754 $ | 71.272.149 $ | +71.272.149 $ |
| Immunocore Holdings plc | IMCR | 29.727.796 $ | -6.938.874 $ | 36.666.670 $ | +36.666.670 $ |
| Burning Rock Biotech Ltd | BNR | 20.046.892 $ | +11.441.154 $ | 8.605.738 $ | +8.605.738 $ |
| UNITED THERAPEUTICS Corp | UTHR | 20.009.793 $ | +20.009.793 $ | ||
| IRONWOOD PHARMACEUTICALS INC | IRWD | 7.161.541 $ | +7.161.541 $ | ||
| GERON CORP | GERN | 4.562.340 $ | -172.816 $ | 4.735.156 $ | +4.735.156 $ |
| OMEROS CORP | OMER | 3.436.000 $ | +3.436.000 $ | ||
| Prelude Therapeutics Inc | PRLD | 2.287.714 $ | +2.287.714 $ | ||
| 1.565.452.855 $ | +249.513.234 $ | 1.343.110.955 $ | +1.343.110.955 $ | ||
Erweiterte Einstellungen
×